Characterization of plasma protein activity in riboflavin and UV light-treated fresh frozen plasma during 2 years of storage at -30 degrees C.
Bihm DJ, Ettinger A, Buytaert-Hoefen KA, Hendrix BK, Maldonado-Codina G, Rock G, Giclas PC, Goodrich RP
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effects of collection method, pathogen reduction with riboflavin addition and UV irradiation, and storage at -30 degrees C on the levels of markers of 10 coagulation, 6 anticoagulant/inhibitor, 4 complement and 6 Ig proteins in FFP from blood donors. Plasma obtained by apheresis with citrate dextrose or from whole blood with citrate phosphate dextrose was held for 8 h at room temperature, aliquots were removed and left at room temperature (control), and the remaining plasma was combined with riboflavin (vitamin B) solution and exposed to UV light. Following light treatment, both the treated plasma and the control plasma were flash frozen and then stored at -30 degrees C.
Summary of Findings
Analysis of plasma collected by apheresis rather than whole-blood derived plasma did not affect the levels of any analyte in FFP. After storage for 36 weeks, 67% of the level of factor VII in control FFP was found in riboflavin/UV-treated FFP, and 64% of the level of factor V in control FFP was measured in riboflavin/UV-treated FFP. After storage for 69 weeks, riboflavin/UV-treated FFP retained 66-94% of the coagulation protein levels found in control FFP. After 87 weeks of storage, riboflavin/UV-treated FFP retained 63% of the factor VIII activity and 57% of the factor XI activity measured in control FFP, while 74-86% of all other coagulation protein levels measured in control FFP were retained in riboflavin/UV-treated FFP. After 104 weeks of frozen storage, 57-90% of the levels of coagulation proteins measured in control FFP were retained in riboflavin/UV-treated FFP, with the greatest loss measured in factor VII. After 69 weeks of storage, 90% or more of the anticoagulant and inhibitor protein levels measured in control FFP were retained in riboflavin/UV-treated FFP. After storage for 69 weeks, significant decreases in C3a, C1 inhibitor antigen, CH50, total IgG, IgG1, IgG4, and IgM were observed in riboflavin/UV-treated FFP compared to levels in control FFP.
Biospecimens
FluidPlasmaFluidBloodPreservation Types
FrozenDiagnoses
NormalPlatforms
ProteinELISAProteinClinical chemistry/auto analyzerGlycoproteinClinical chemistry/auto analyzerPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Method of fluid acquisition ApheresisVenipunctureBiospecimen Acquisition Pre-preservation condition No riboflavin/UV light exposureTreated with riboflavin and UV light exposureBiospecimen Aliquots and Components Blood processing method No riboflavin/UV light exposureTreated with riboflavin and UV light exposureStorage Storage duration 104 weeks36 weeks69 weeks87 weeks